Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Abrocitinib 200mg tablets
1305030K0AAABAB
|
Abrocitinib | Abrocitinib | Skin | No data available |
|
Abrocitinib 50mg tablets
1305030K0AAACAC
|
Abrocitinib | Abrocitinib | Skin | No data available |
|
Abtrim 1% cream
1310020H0BIAAAB
|
Abtrim (Topical) | Clotrimazole | Skin | No data available |
|
Acitretin 10mg/5ml oral solution
1305020A0AAAFAF
|
Acitretin | Acitretin | Skin | No data available |
|
Acitretin 10mg/5ml oral suspension
1305020A0AAADAD
|
Acitretin | Acitretin | Skin | No data available |
|
Acitretin 5mg/5ml oral solution
1305020A0AAACAC
|
Acitretin | Acitretin | Skin | No data available |
|
Acnecide Face 5% gel
1306010C0BUADAB
|
Acnecide | Benzoyl peroxide | Skin | No data available |
|
Acnisal 2% solution
1306010Q0BBAAAA
|
Acnisal | Salicylic acid | Skin | No data available |
|
Acnocin 2000microgram/35microgram tablets
1306020C0BCAAAA
|
Acnocin | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | No data available |
|
Acorvio 2% cream
1310020N0BDABAA
|
Acorvio | Miconazole nitrate | Skin | No data available |
|
Acorvio Plus cream
1304000ACBBAAAA
|
Acorvio (Corticosteroid) | Fluprednidene acetate | Skin | No data available |
|
Acticin 0.025% cream
1306010V0BDAAAE
|
Acticin | Tretinoin | Skin | No data available |
|
ActiDerm 1% cream
1303000AABGAAAB
|
ActiDerm | Menthol | Skin | No data available |
|
Actinac lotion
1306010G0BBAAAA
|
Actinac | Corticosteroids | Skin | No data available |
|
Adtralza 150mg/1ml inj pre-filled syringes
1305030J0BBAAAA
|
Adtralza | Tralokinumab | Skin | No data available |
|
Adtralza 300mg/2ml solution for injection pre-filled pens
1305030J0BBABAB
|
Adtralza | Tralokinumab | Skin | No data available |
|
Aindeem 1mg tablet
1309000W0BCAAAA
|
Aindeem | Finasteride | Skin | No data available |
|
Alclometasone 0.05% ointment
1304000B0AABABA
|
Alclometasone dipropionate | Alclometasone dipropionate | Skin | No data available |
|
Alcoderm cream
130201000BBASAR
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Alcoderm lotion
130201000BBATAS
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Aldioxa 0.22% / Chloroxylenol 0.5% powder
131200000AAAHAH
|
Generic compound preparation BNF 1312000 | Other antiperspirant preparations | Skin | No data available |
|
Allergenics Intensive Care ointment
130201000BBJVA0
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Alpha Keri bath oil
1302011M0BFAAAA
|
Alpha Keri | Liquid paraffin | Skin | No data available |
|
Alphaderm 1%/10% cream
1304000V0BWAAAN
|
Alphaderm | Hydrocortisone | Skin | No data available |
|
Alphosyl cream
1305020C0BHAABA
|
Alphosyl (Topical) | Tars | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.